Literature DB >> 2162214

Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes.

V Lefebvre1, C Peeters-Joris, G Vaes.   

Abstract

The actions of interleukin 1 (IL1) and tumor necrosis factor alpha (TNF alpha) on several parameters of the collagen metabolism of rabbit articular chondrocytes were studied by comparing the responses of either differentiated chondrocytes in primoculture or dedifferentiated cells in late passage culture to human recombinant (hr) IL1 alpha, hr-TNF alpha and cytokine-enriched fractions of rabbit macrophage-conditioned media. In response to IL1 or TNF alpha, differentiated chondrocytes (i.e., producing the cartilage-specific collagens, types II and XI, but no type I), sharply reduced their synthesis of collagen, a reduction which involved both types II and XI collagens, without consistently changing their production of non-collagenous proteins; they also incorporated a smaller proportion of collagen into the matrix. Similar levels of response were obtained for hr-IL1 alpha at picomolar and for hr-TNF alpha at nanomolar concentrations. However, the action of TNF alpha, but not of IL1, was manifested only in the presence of serum. Simultaneously, IL1, but not TNF alpha, induced the chondrocyte production of procollagenase (a difference which contrasted with the similar levels of procollagenase induced by both cytokines in synovial and skin fibroblasts) but neither cytokine influenced the accumulation of the collagenase inhibitor TIMP. These effects were not affected by indomethacin and are thus unlikely to be prostaglandin-mediated. During their dedifferentiation in monolayer subcultures, chondrocytes became more sensitive to the procollagenase-inducing ability of IL1 and TNF alpha, but their response to TNF alpha was lower than to IL1. They also increased their production of TIMP, which remained unaffected by the cytokines. Simultaneously, they decreased their production of collagen and substituted progressively the synthesis of fibroblast-specific collagens, types I, III and V, for types II and XI. Acting on dedifferentiated cells, even in the presence of indomethacin, IL1 and TNF alpha further decreased the synthesis of collagen, reducing the production of both typical type I (i.e. [alpha 1(I)]2 x alpha 2(I) molecules) and type V collagens as well as their incorporation into the matrix, but increasing the synthesis of type III collagen. Therefore not only IL1, but also TNF alpha can exert profound influences on the collagen degradation and repair processes occurring in the pathology of articular cartilage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162214     DOI: 10.1016/0167-4889(90)90145-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  72 in total

Review 1.  A current review of molecular mechanisms regarding osteoarthritis and pain.

Authors:  Andrew S Lee; Michael B Ellman; Dongyao Yan; Jeffrey S Kroin; Brian J Cole; Andre J van Wijnen; Hee-Jeong Im
Journal:  Gene       Date:  2013-07-02       Impact factor: 3.688

2.  Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis.

Authors:  Xufang Zhang; Ross Crawford; Yin Xiao
Journal:  J Mol Med (Berl)       Date:  2016-05-10       Impact factor: 4.599

Review 3.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

Review 4.  Cytokine networking of chondrocyte dedifferentiation in vitro and its implications for cell-based cartilage therapy.

Authors:  Li Duan; Bin Ma; Yujie Liang; Jielin Chen; Weimin Zhu; Mingtao Li; Daping Wang
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

Review 5.  Platelet-Rich Plasma and Cartilage Repair.

Authors:  Mitchell I Kennedy; Kaitlyn Whitney; Thos Evans; Robert F LaPrade
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

6.  The regional sensitivity of chondrocyte gene expression to coactive mechanical load and exogenous TNF-α stimuli.

Authors:  S L Bevill; K A Boyer; T P Andriacchi
Journal:  J Biomech Eng       Date:  2014-09       Impact factor: 2.097

7.  Oral Administration of a Chemically Modified Curcumin, TRB-N0224, Reduced Inflammatory Cytokines and Cartilage Erosion in a Rabbit ACL Transection Injury Model.

Authors:  Josephine R Coury; Ryan Nixon; Melinda Collins; John Schwartz; Nadeen O Chahine; Daniel A Grande
Journal:  Cartilage       Date:  2018-11-28       Impact factor: 4.634

8.  The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.

Authors:  Makoto Osaki; Lujian Tan; Bob K Choy; Yasuhiro Yoshida; Kathryn S E Cheah; Philip E Auron; Mary B Goldring
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

9.  Synovial reaction and concentrations of proteoglycan fragments in joint fluid after intraarticular knee injuries.

Authors:  K Messner; J Gao
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1995       Impact factor: 4.342

10.  MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses.

Authors:  Shigeru Miyaki; Tomoyuki Nakasa; Shuhei Otsuki; Shawn P Grogan; Reiji Higashiyama; Atsushi Inoue; Yoshio Kato; Tempei Sato; Martin K Lotz; Hiroshi Asahara
Journal:  Arthritis Rheum       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.